603 related articles for article (PubMed ID: 16170181)
1. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
2. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
Pawlik TM; Ross MI; Prieto VG; Ballo MT; Johnson MM; Mansfield PF; Lee JE; Cormier JN; Gershenwald JE
Cancer; 2006 Feb; 106(4):900-6. PubMed ID: 16411225
[TBL] [Abstract][Full Text] [Related]
4. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
5. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
7. Wide excision without radiation for desmoplastic melanoma.
Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
[TBL] [Abstract][Full Text] [Related]
8. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
9. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
10. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
11. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
Mohebati A; Ganly I; Busam KJ; Coit D; Kraus DH; Shah JP; Patel SG
Ann Surg Oncol; 2012 Dec; 19(13):4307-13. PubMed ID: 22766985
[TBL] [Abstract][Full Text] [Related]
12. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma in pregnancy. A population-based evaluation.
O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L
J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients.
Murali R; Shaw HM; Lai K; McCarthy SW; Quinn MJ; Stretch JR; Thompson JF; Scolyer RA
Cancer; 2010 Sep; 116(17):4130-8. PubMed ID: 20564101
[TBL] [Abstract][Full Text] [Related]
20. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
